2020. Dose Adjustment Patterns in the Open-Label Extension Arms of Three Phase 3 Trials of Certolizumab Pegol in Psoriasis: CIMPASI-1, CIMPASI-2, and CIMPACT. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s85. DOI:https://doi.org/10.25251/skin.4.supp.85.